Scandinavian Chemotech: An eventful period - Redeye

Over the past week, several noteworthy events have occurred while Scandinavian Chemotech’s TO3 moves towards the end of its subscription period. Redeye provides a brief commentary on all the updates that have taken place, and our valuation range remains unchanged.

Länk till analysen i sin helhet: https://www.redeye.se/research/896238/scandinavian-chemotech-an-eventful-period?utm_source=finwire&utm_medium=RSS